BE795970A - Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant - Google Patents
Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenantInfo
- Publication number
- BE795970A BE795970A BE795970DA BE795970A BE 795970 A BE795970 A BE 795970A BE 795970D A BE795970D A BE 795970DA BE 795970 A BE795970 A BE 795970A
- Authority
- BE
- Belgium
- Prior art keywords
- quinoleine
- quinoxaline
- quinazoline
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919672A GB1381979A (en) | 1972-02-29 | 1972-02-29 | Amino derivatives of quinoline quinoxaline and quinazoline |
| GB5162972 | 1972-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE795970A true BE795970A (fr) | 1973-08-27 |
Family
ID=26242776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE795970D BE795970A (fr) | 1972-02-29 | Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3890319A (ru) |
| JP (2) | JPS5754516B2 (ru) |
| AR (1) | AR213705A1 (ru) |
| AU (1) | AU471598B2 (ru) |
| BE (1) | BE795970A (ru) |
| CA (1) | CA981678A (ru) |
| CH (2) | CH576975A5 (ru) |
| DE (1) | DE2309160A1 (ru) |
| ES (2) | ES411804A1 (ru) |
| FI (1) | FI63757C (ru) |
| FR (1) | FR2181776B1 (ru) |
| GB (1) | GB1381979A (ru) |
| IE (1) | IE37519B1 (ru) |
| MX (1) | MX3042E (ru) |
| NL (1) | NL159102B (ru) |
| SE (1) | SE417204B (ru) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1463520A (en) * | 1974-09-06 | 1977-02-02 | Pfizer Ltd | Process for the production of imidazolines |
| JPS5373571A (en) * | 1976-12-10 | 1978-06-30 | Otsuka Pharmaceut Co Ltd | Carbostyril derivatives |
| US4188393A (en) | 1977-04-22 | 1980-02-12 | Sandoz Ltd. | Treating spastic conditions or relaxing muscles |
| US4145421A (en) | 1977-04-22 | 1979-03-20 | Sandoz Ltd. | Treating spastic conditions |
| FR2449087A2 (fr) * | 1979-02-16 | 1980-09-12 | Rhone Poulenc Ind | Nouveaux derives de l'isoquinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US4486432A (en) * | 1982-09-30 | 1984-12-04 | Eli Lilly And Company | Quinoxalinedione leukotriene release inhibitors |
| FR2541680B1 (fr) * | 1983-02-24 | 1985-06-14 | Rhone Poulenc Sante | Nouveaux derives de l'amino-5 dithiole-1,2 one-3, leur preparation et les compositions medicinales qui les contiennent |
| JPS6118950U (ja) * | 1984-07-10 | 1986-02-03 | 財団法人鉄道総合技術研究所 | トロリ線の給油装置 |
| JPS63296814A (ja) * | 1987-05-29 | 1988-12-02 | Ishigaki Kiko Kk | 集塵装置における濾材の目詰り除去装置 |
| GB8827820D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
| US5281591A (en) * | 1989-05-22 | 1994-01-25 | Allergan, Inc. | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
| US5180721A (en) * | 1989-05-22 | 1993-01-19 | Allergan, Inc. | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
| US5231096A (en) * | 1989-10-12 | 1993-07-27 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| US5112822A (en) * | 1989-10-12 | 1992-05-12 | Allergan, Inc. | (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| US5077292A (en) * | 1989-10-12 | 1991-12-31 | Allergan, Inc. | (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| US5204347A (en) * | 1989-10-12 | 1993-04-20 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines |
| US5326763A (en) * | 1989-10-12 | 1994-07-05 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| US5198442A (en) * | 1989-10-12 | 1993-03-30 | Allergan, Inc. | (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| US5021416A (en) * | 1989-10-31 | 1991-06-04 | Allergan, Inc. | Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure |
| US5215991A (en) * | 1990-01-26 | 1993-06-01 | Allergan, Inc. | Combination of selective alpha-adrenergic agonists and Na+ /H+ ex |
| US5130441A (en) * | 1990-02-06 | 1992-07-14 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
| US5237072A (en) * | 1990-02-06 | 1993-08-17 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
| US5252595A (en) * | 1990-02-28 | 1993-10-12 | Allergan, Inc. | Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines |
| US5091528A (en) * | 1990-09-12 | 1992-02-25 | Allergan, Inc. | 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
| WO1995010280A1 (en) * | 1993-10-13 | 1995-04-20 | Allergan | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| US6323204B1 (en) * | 1993-10-13 | 2001-11-27 | Allergan | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| US5580892A (en) * | 1993-10-22 | 1996-12-03 | Allergan | Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents |
| US5578607A (en) * | 1993-12-17 | 1996-11-26 | The Procter & Gamble Company | 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| US5478858A (en) * | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
| US5576437A (en) * | 1993-12-17 | 1996-11-19 | The Procter & Gamble Company | 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
| AU699041B2 (en) * | 1993-12-17 | 1998-11-19 | Board Of Regents Of The University Of Nebraska, The | 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| DK0735877T3 (da) * | 1993-12-17 | 2000-11-06 | Procter & Gamble | 6-(2-imidazolinylamino)quinoxalinforbindelser, der er egnede som alfa-2-adrenoceptoragonister. |
| NZ281460A (en) * | 1994-02-08 | 1996-10-28 | Alcon Lab Inc | Processes for preparation of clonidine derivatives, intermediate complexes and process for preparation of the intermediates |
| CA2196792A1 (en) | 1994-08-04 | 1996-02-15 | Yoon T. Jeon | Novel benzimidazole derivatives |
| US6294563B1 (en) | 1994-10-27 | 2001-09-25 | Allergan Sales, Inc. | Combinations of prostaglandins and brimonidine or derivatives thereof |
| US6194415B1 (en) * | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
| US5916900A (en) | 1995-06-29 | 1999-06-29 | The Procter & Gamble Company | 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| DE69732244T2 (de) | 1996-11-25 | 2006-06-29 | The Board Of Regents Of The University Of Nebraska, Lincoln | Guanidyl-heterocyclische verbindungen als alpha-2 adrenoceptor agonisten |
| US6172095B1 (en) | 1996-11-25 | 2001-01-09 | The Procter & Gamble Company | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| JP2001506981A (ja) * | 1996-11-25 | 2001-05-29 | ザ プロクター アンド ギャンブル カンパニー | α―２アドレナリン受容体作動薬として有用な２―イミダゾリニルアミノインドール化合物 |
| WO1998023612A1 (en) * | 1996-11-25 | 1998-06-04 | The Procter & Gamble Company | 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists |
| BR9713537A (pt) * | 1996-11-25 | 2000-03-21 | Procter & Gamble | omo agonistas a alfa-2-adrenorreceptor |
| US6306877B1 (en) | 1999-08-09 | 2001-10-23 | The Procter & Gamble Co. | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| US6495583B1 (en) | 1997-03-25 | 2002-12-17 | Synaptic Pharmaceutical Corporation | Benzimidazole derivatives |
| CN1284073A (zh) | 1997-11-24 | 2001-02-14 | 宝洁公司 | 5－(2－咪唑啉基氨基)－苯并咪唑衍生物,其制备和作为具有改进的代谢稳定性的a－肾上腺素能受体激动剂的应用 |
| US6242442B1 (en) | 1998-12-17 | 2001-06-05 | Alcon Laboratories, Inc. | Brinzolamide and brimonidine for treating ocular conditions |
| US8858961B2 (en) * | 2000-07-14 | 2014-10-14 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| US20050026924A1 (en) * | 2000-07-14 | 2005-02-03 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| WO2002005853A2 (en) | 2000-07-14 | 2002-01-24 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| BR0112461A (pt) * | 2000-07-14 | 2003-07-22 | Allergan Inc | Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada |
| US20040214829A1 (en) * | 2000-07-14 | 2004-10-28 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| DE10161767A1 (de) * | 2001-12-15 | 2003-06-26 | Merck Patent Gmbh | 2-Guanidino-4-heterocyclyl-chinazoline |
| US7030149B2 (en) | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
| US7642258B2 (en) * | 2002-04-19 | 2010-01-05 | Allergan, Inc. | Combination of brimonidine and timolol for topical ophthalmic use |
| ATE429216T1 (de) * | 2002-10-08 | 2009-05-15 | Allergan Inc | Alpha 2b oder 2b/2c adrenozeptor-agonisten zur behandlung von morbus alzheimer und morbus parkinson |
| PL376347A1 (en) * | 2002-10-08 | 2005-12-27 | Allergan, Inc. | Method of using (2-imidazolin-2-ylamino) qinoxalines in the treatment of dementia and parkinsons |
| US20040191332A1 (en) * | 2003-03-27 | 2004-09-30 | Allergan, Inc. | Preserved ophthalmic compositions |
| US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| BRPI0413381A (pt) | 2003-08-07 | 2006-10-17 | Allergan Inc | composições para liberação de compostos terapêuticos nos olhos e processos para fabricação e uso das mesmas |
| EP1660090B1 (en) * | 2003-08-14 | 2012-11-21 | Array Biopharma, Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
| US7501427B2 (en) | 2003-08-14 | 2009-03-10 | Array Biopharma, Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
| US20070042951A1 (en) * | 2003-10-08 | 2007-02-22 | Allergan, Inc. | Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides |
| DK1761266T3 (da) | 2004-05-25 | 2013-08-05 | Galderma Pharma Sa | Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme |
| US7534795B2 (en) * | 2005-10-25 | 2009-05-19 | Allergan, Inc. | Compounds and their use related to compositions for treating disease |
| NZ568694A (en) | 2005-11-09 | 2011-09-30 | Zalicus Inc | Method, compositions, and kits for the treatment of medical conditions |
| DE602006021645D1 (de) | 2005-11-15 | 2011-06-09 | Array Biopharma Inc | Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten |
| WO2008074068A1 (en) * | 2006-12-20 | 2008-06-26 | Prana Biotechnology Limited | Substituted quinoline derivatives as antiamyloidogeneic agents |
| US20080293728A1 (en) * | 2007-05-18 | 2008-11-27 | Mcintire Gregory L | Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions |
| US7842714B2 (en) * | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
| US9192571B2 (en) * | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| EP2486009B1 (en) | 2009-10-06 | 2019-08-21 | Allergan, Inc. | 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| EP2329849B1 (en) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
| US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| CA2792646C (en) | 2010-03-26 | 2018-11-20 | Galderma Research & Development | Improved uses and compositions for safe and effective treatment of erythema |
| KR20130010122A (ko) | 2010-03-26 | 2013-01-25 | 갈데르마 리써어치 앤드 디벨로프먼트 | 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물 |
| KR20130041803A (ko) | 2010-04-07 | 2013-04-25 | 알러간, 인코포레이티드 | 안과 조성물을 위한 보존제의 조합 |
| AU2011237677A1 (en) | 2010-04-07 | 2012-11-08 | Allergan, Inc. | Combinations of preservative compositions for ophthalmic formulations |
| US10213431B2 (en) | 2010-07-29 | 2019-02-26 | Allergan, Inc. | Preservative free brimonidine and timolol solutions |
| US20130261126A1 (en) | 2010-10-21 | 2013-10-03 | Galderma S.A. | Brimonidiine gel compositions and methods of use |
| US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
| CA2843251A1 (en) | 2011-07-25 | 2013-01-31 | Santosh C. Sinha | N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| GR1009419B (el) | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3560501A (en) * | 1966-09-15 | 1971-02-02 | Ciba Geigy Corp | Process for making dihydroquinazolines |
| US3594380A (en) * | 1969-02-18 | 1971-07-20 | American Home Prod | Isoquinolin-1(2h)-ones |
| BE766039A (fr) * | 1971-04-21 | 1971-09-16 | Labofina Sa | Nouveaux polymeres contenant des unites de pyrazole et procede de preparation de ces polymeres. |
-
0
- BE BE795970D patent/BE795970A/xx not_active IP Right Cessation
-
1972
- 1972-02-29 GB GB919672A patent/GB1381979A/en not_active Expired
-
1973
- 1973-02-08 AU AU51985/73A patent/AU471598B2/en not_active Expired
- 1973-02-13 SE SE7302024A patent/SE417204B/xx unknown
- 1973-02-14 FI FI436/73A patent/FI63757C/fi active
- 1973-02-14 IE IE236/73A patent/IE37519B1/xx unknown
- 1973-02-14 US US332485A patent/US3890319A/en not_active Expired - Lifetime
- 1973-02-15 MX MX129473U patent/MX3042E/es unknown
- 1973-02-20 ES ES411804A patent/ES411804A1/es not_active Expired
- 1973-02-21 JP JP48020280A patent/JPS5754516B2/ja not_active Expired
- 1973-02-22 CA CA164,361A patent/CA981678A/en not_active Expired
- 1973-02-23 AR AR246774A patent/AR213705A1/es active
- 1973-02-23 DE DE19732309160 patent/DE2309160A1/de active Pending
- 1973-02-27 ES ES412102A patent/ES412102A1/es not_active Expired
- 1973-02-28 CH CH293873A patent/CH576975A5/xx not_active IP Right Cessation
- 1973-02-28 NL NL7302799.A patent/NL159102B/xx not_active IP Right Cessation
- 1973-02-28 FR FR7307157A patent/FR2181776B1/fr not_active Expired
- 1973-02-28 CH CH149075A patent/CH577500A5/xx not_active IP Right Cessation
-
1980
- 1980-07-11 JP JP9493480A patent/JPS5625176A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NL159102B (nl) | 1979-01-15 |
| AU5198573A (en) | 1974-08-08 |
| JPS5754516B2 (ru) | 1982-11-18 |
| CH576975A5 (ru) | 1976-06-30 |
| JPS5745439B2 (ru) | 1982-09-28 |
| SE417204B (sv) | 1981-03-02 |
| US3890319A (en) | 1975-06-17 |
| ES411804A1 (es) | 1976-05-01 |
| FR2181776A1 (ru) | 1973-12-07 |
| FI63757C (fi) | 1983-08-10 |
| FR2181776B1 (ru) | 1976-08-13 |
| IE37519B1 (en) | 1977-08-17 |
| FI63757B (fi) | 1983-04-29 |
| CA981678A (en) | 1976-01-13 |
| ES412102A1 (es) | 1976-05-16 |
| GB1381979A (en) | 1975-01-29 |
| AR213705A1 (es) | 1979-03-15 |
| JPS4897878A (ru) | 1973-12-13 |
| AU471598B2 (en) | 1976-04-29 |
| JPS5625176A (en) | 1981-03-10 |
| MX3042E (es) | 1980-03-04 |
| IE37519L (en) | 1973-08-29 |
| NL7302799A (ru) | 1973-08-31 |
| CH577500A5 (ru) | 1976-07-15 |
| DE2309160A1 (de) | 1973-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE795970A (fr) | Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant | |
| FR2279406A1 (fr) | Nouveaux derives de quinazoline et medicament les contenant | |
| BE804558A (fr) | Nouveaux derives de 2-amino- ou 4-amino-quinazoline et medicaments les contenant | |
| BE787103A (fr) | Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant | |
| BE855713Q (fr) | Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et medicament les contenant | |
| BE750192A (fr) | Nouveaux derives de la quinazolinone, leur preparation et medicaments contenant ces derives | |
| BE746301A (fr) | Nouveaux benzylimidazoles alpha, alpha-disubstitues, leur procede de preparation et compositions pharmaceutiques les contenant | |
| BE811856A (fr) | Nouveaux derives de quinazoline et composition pharmaceutique les contenant | |
| BE802996R (fr) | Nouveaux derives de la 4-amino-quinazolines, leur preparation et medicaments contenant ces derives | |
| BE794226A (fr) | Derives de la quinoleine, leur preparation et les medicaments qui en contiennent | |
| BE746756A (fr) | Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces derives | |
| BE759176A (fr) | Derives de la pyrimidine, leur preparation et medicaments contenant cesderives | |
| BE806854A (fr) | Nouvelles urees tricycliques, leur preparation et les compositions pharmaceutiques en contenant | |
| FR2290193A1 (fr) | Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant | |
| BE803474A (fr) | Nouvelles 2-alkylamino-dihydropyridines, leur procede de preparation et compositions pharmaceutiques les contenant | |
| BE777911A (fr) | Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant | |
| BE775294A (fr) | Nouveaux derives de la pyridazine, leur preparation et medicaments les contenant | |
| BE808094A (fr) | Nouveaux derives de propanolamine et composition pharmaceutique les contenant | |
| BE759842R (fr) | Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces | |
| BE766588A (fr) | Derives de la piperazine, leur preparation et medicaments contenant cesderives | |
| BE803373A (fr) | Nouveaux derives de 1,4-benzene-disulfamide et composition pharmaceutique les contenant | |
| BE766587A (fr) | Derives de la piperazine, leur preparation et medicaments en contenant | |
| BE761713A (fr) | Nouvelles pyrrolidines substituees, leur preparation et compositions pharmaceutiques les contenant | |
| BE776315A (fr) | Nouveaux derives de la 1-amino-isoquinoleine, leur preparation et leur application comme medicaments | |
| BE744626A (fr) | Nouveaux derives de la pyridazine,leur preparation et medicaments contenant ces derives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: PFIZER CORP. Effective date: 19920228 |